Leonora Pierce
 |
Fluid volume expansion, side effects contraceptive pills vasoconstriction, and the sympathetic nervous system. A rise in blood pressure occurs in virtually all women who use ortho tri cyclen OCs for 6 months or longer. Discernible increases in blood pressure normally occur as early as 6 months after OC use begins, and the greatest increase in blood pressure is usually seen ortho tri cyclen during the 1st 2 years of OC use. Several generic seasonale aspects of the relationship of OCs to blood pressure and to cardiovascular diseases can be summarized. Estrogens and hypertension.New information concerning the risk of mild unrecognized increased in buy seasonale without prescription blood pressure on mortality and a new definition of normal blood pressure contraceptive pills levels necessitate reevaluation of the relationships between oral contraceptives (OCs) or Estrogens and blood pressure changes. After 5 years ortho tricyclen of OC use, a mean increase in systolic pressure of 12.3 mm Hg and of diastolic, 8.8 mm Hg was seen in these normotensive females. In some patients the severity of the hypertension or the presence of ortho tri-cyclen complications necessitates emergency treatment. The influence of Estrogens on these factors is reviewed. These include cigarette smoking, diabetes, and hyperlipidemia. In general, any of these ortho tri-cyclen mechanisms can increase blood pressure independently or in combination. The use of diuretics, antisympathetic agents, vasodilators, and parenteral agents for malignant hypertension represents an appropriate sequence to follow in such cases.. These prospective studies involved 60,000 women, 35,000 of them using birth control pills. The increase in blood pressure associated with OC administration is generally mild, yet it may be progressive. The current evidence indicates that a high risk group likely to develop contraceptive hypertension cannot be identified, but there are characteristics which are known to increase the risk of cardiovascular disease such as heart attacks and strokes in all OC users. It is prudent to monitor blood pressure at least every 6 months in women receiving Estrogens and OCs. Developing the most effective therapeutic approach to Estrogen induced hypertension, when withdrawal of the Estrogen source is not feasible, would be enhanced by a clear understanding of the mechanisms by which the hypertension occurs. When hypertension is encountered in a woman receiving Estrogens, the ideal 1st step is discontinuation of the Estrogen source. In such susceptible persons, extreme caution is advised in prescribing Estrogens in order to reduce the likelihood of premature cardiovascular disease.
|